from Reuters: Top News http://uk.reuters.com/article/uk-astrazeneca-results/astrazeneca-profit-outlook-disappoints-despite-drug-sales-growth-idUKKBN1FM0PV?feedType=RSS&feedName=topNews
Friday, 2 February 2018
AstraZeneca profit outlook disappoints, despite drug sales growth
LONDON (Reuters) - AstraZeneca expects to return to drug sales growth in 2018 as new medicines win market share and the group puts patent losses behind it, although the need to invest in launches will weigh on profit.
from Reuters: Top News http://uk.reuters.com/article/uk-astrazeneca-results/astrazeneca-profit-outlook-disappoints-despite-drug-sales-growth-idUKKBN1FM0PV?feedType=RSS&feedName=topNews
from Reuters: Top News http://uk.reuters.com/article/uk-astrazeneca-results/astrazeneca-profit-outlook-disappoints-despite-drug-sales-growth-idUKKBN1FM0PV?feedType=RSS&feedName=topNews
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment